SEC Filing Document

Company: BIOVENTRIX, INC.
Ticker: 
CIK: 1283259
Filing Type: S-1
Document Type: EX-3.5
Date Filed: 2026-02-12
Accession Number: 0001493152-26-006407
Exchange: 
SIC Code: 3841
SIC Description: Surgical & Medical Instruments & Apparatus
URL: https://www.sec.gov/Archives/edgar/data/1283259/000149315226006407/ex3-5.htm

Chunk 1 of 3
Word Count: 1264
Character Count: 7629

Document Content:

up of the Corporation (and distribution of the net assets of the Corporation in connection therewith); the terms and conditions, if any, upon which shares of such class or series shall be convertible into, or exchangeable for, shares of capital stock of any other class or series, including the price or prices or the rate or rates of conversion or exchange, the terms and conditions of conversion or exchange, and the terms of adjustment, if any; the obligation, if any, of the Corporation to retire, redeem or purchase shares of such class or series pursuant to a sinking fund or fund of a similar nature or otherwise, and the terms and conditions of such obligation; voting rights, if any, including special, conditional or limited voting rights with respect to any matter, including with respect to the election of directors and matters adversely affecting any class or series of Preferred Stock;

limitations, if any, on the issuance of additional shares of such class or series or any shares of any other class or series of
Preferred Stock; and

such other preferences, limitations or relative rights and privileges thereof as the Board of Directors, acting in accordance with
applicable law and this Certificate of Incorporation, may deem advisable and which are not inconsistent with law or with the
provisions of this Certificate of Incorporation.

Options, Warrants & Rights.

The Corporation may issue options, warrants and rights for the purchase of shares of any class or series of the Corporation. The
Board of Directors, in its sole discretion, shall determine the terms and conditions on which the options, warrants or rights are
issued, their form and content and the consideration for which, and terms and conditions upon which, such securities or any
underlying class or series of shares of the Corporation are to be issued.

The terms and conditions of rights or options to purchase shares of any class or series of the Corporation may include, without
limitation, restrictions or conditions that preclude or limit the exercise, transfer, receipt or holding of such rights or options
by any person or persons, including any person or persons owning (beneficially or of record) or offering to acquire a specified
number or percentage of the outstanding shares of any class or series, or any transferee or transferees of any such person or
persons, or that invalidate or void such rights or options held by any such person or persons or any such transferee or
transferees.

FIFTH:
The following provisions are inserted for the management of the business and for the conduct of the affairs of the Corporation, and
for further definition, limitation and regulation of the powers of the Corporation and of its directors and stockholders:

The Corporation expressly elects not to be governed by Section 203 of the DGCL.

Election of directors need not be by ballot unless the bylaws of the Corporation so provide.

The Board shall have the power, without the assent or vote of the stockholders, to make, alter,
amend, change, add to or repeal the bylaws of the Corporation.

No contract or other transaction between the Corporation and one or more of its directors, or between the Corporation and any other
corporation, firm, association or other entity in which one or more of the directors are directors or officers, or are financially
interested, shall be either void or voidable because of such relationship or interest or because such director or directors are
present at the meeting of the Board of Directors or a committee thereof which authorizes, approves or ratifies such contract or
transaction or because his or her votes are counted for such purpose, if:

The fact of such relationship or interest is disclosed or known to the Board of Directors, or a duly empowered committee thereof,
which authorizes, approves or ratifies the contract or transaction by a vote or consent sufficient for such purpose without counting
the vote or votes of such interested director or directors; or

The fact of such relationship or interest is disclosed or known to the stockholders entitled to vote and they authorize, approve or
ratify such contract or transaction by vote or written consent; or

(iii)
The contract or transaction is fair and reasonable as to the Corporation at the time it is authorized by the Board of Directors,
committee or the stockholders.

Common or interested directors may be counted in determining the presence of a quorum at a meeting of the Board of Directors or a
committee thereof which authorizes, approves or ratifies a contract or transaction described in paragraph (d) of this Article
FIFTH.

A director of the Corporation may transact business, borrow, lend, or otherwise deal or contract with the Corporation to the fullest
extent and subject only to the limitations and provisions of the laws of the State of Delaware and the laws of the United
States.

The Board of Directors in its discretion may (but shall not be required to) submit any contract or act for approval or ratification
at any annual meeting of the stockholders or at any meeting of the stockholders called for the purpose of considering any such act
or contract, and any contract or act that shall be approved or be ratified by the vote of the holders of a majority of the stock of
the Corporation which is represented in person or by proxy at such meeting and entitled to vote thereat (provided that a lawful
quorum of stockholders be there represented in person or by proxy) shall be valid and binding upon the Corporation and upon all the
stockholders as though it had been approved or ratified by every stockholder of the Corporation, regardless of whether the contract
or act would otherwise be open to legal challenge because of directors’ interests, or for any other reason.

In addition to the powers and authorities hereinbefore or by statute expressly conferred upon
them, the directors are hereby empowered to exercise all such powers and do all such acts and things as may be exercised or done by the
Corporation; subject, nevertheless, to the provisions of the statutes and laws of the State of Delaware, of this Certificate of Incorporation,
and to any bylaws from time to time made by the stockholders; provided, however, that no bylaw so made shall invalidate
any prior act of the directors, which would otherwise have been valid if such bylaw had not been made.

SIXTH: No
director or officer of the Corporation shall have any personal liability to the Corporation or its stockholders for monetary damages
for any breach of fiduciary duty as a director or officer, except to the extent such exemption from liability or limitation thereof is
not permitted under the DGCL as the same exists or hereafter may be amended. If the DGCL is amended after approval by the stockholders
of this Article SIXTH to authorize corporate action further eliminating or limiting the personal liability of directors or officers,
then the liability of a director or officer of the Corporation shall be eliminated or limited to the fullest extent permitted by the
DGCL as so amended, automatically and without further action, upon the date of such amendment. Neither any amendment nor repeal of this
Article SIXTH, nor the adoption by amendment of this Certificate of Incorporation of any provision inconsistent with this Article SIXTH,
shall eliminate or reduce the effect of this Article SIXTH in respect of any matter occurring, or any action or proceeding accruing or
arising (or that, but for this Article SIXTH, would accrue or arise) prior to such amendment or repeal or adoption of an inconsistent
provision.